| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.95 | 0.003 | 0.95 | Bronchodilator | 0.811 0.003 DBMET01000 | ||
| 0.83 | 0.004 | 0.83 | Spasmolytic | 0.719 0.005 DBMET01000 | ||
| 0.78 | 0.006 | 0.78 | Antiobesity | 0.764 0.007 DBMET01000 | ||
| 0.762 | 0.004 | 0.762 | Antiadrenergic | 0.543 0.005 DBMET01000 | ||
| 0.761 | 0.004 | 0.761 | Adrenaline antagonist | 0.543 0.005 DBMET01000 | ||
| 0.716 | 0.008 | 0.716 | Toll-Like receptor agonist | 0.424 0.051 DBMET01000 | ||
| 0.713 | 0.008 | 0.713 | Toll-Like receptor 7 agonist | 0.386 0.066 DBMET01000 | ||
| 0.685 | 0.007 | 0.685 | Vasodilator, peripheral | 0.254 0.124 DBMET01000 | ||
| 0.673 | 0.001 | 0.673 | Adrenaline agonist | 0.342 0.003 DBMET01000 | ||
| 0.686 | 0.015 | 0.686 | Cyclophilin D inhibitor | 0.652 0.019 DBMET01000 | ||
| 0.658 | 0.004 | 0.658 | Calcium channel L-type activator | 0.599 0.006 DBMET01000 | ||
| 0.61 | 0.004 | 0.61 | Interleukin agonist | 0.294 0.051 DBMET01000 | ||
| 0.609 | 0.004 | 0.609 | Anesthetic local | 0.181 0.037 DBMET01000 | ||
| 0.579 | 0.001 | 0.579 | Beta adrenoreceptor agonist | 0.199 0.003 DBMET01000 | ||
| 0.528 | 0.012 | 0.528 | Vasodilator, coronary | 0.306 0.082 DBMET01000 | ||
| 0.527 | 0.04 | 0.527 | Transcription factor NF kappa B inhibitor | 0.301 0.093 DBMET01000 | ||
| 0.487 | 0.004 | 0.487 | Expectorant | 0.229 0.015 DBMET01000 | ||
| 0.511 | 0.031 | 0.603 | Cholesterol antagonist | 0.603 0.018 DBMET01000 | DBMET01000 | |
| 0.476 | 0.002 | 0.476 | Beta adrenoreceptor antagonist | 0.171 0.005 DBMET01000 | ||
| 0.486 | 0.016 | 0.486 | Hypoxia-inducible factor 1 alpha inhibitor | 0.227 0.122 DBMET01000 | ||
| 0.485 | 0.017 | 0.485 | Cardiotonic | 0.312 0.051 DBMET01000 | ||
| 0.458 | 0.014 | 0.458 | Interleukin 2 agonist | 0.345 0.048 DBMET01000 | ||
| 0.445 | 0.001 | 0.445 | Beta 1 adrenoreceptor agonist | 0.074 0.003 DBMET01000 | ||
| 0.441 | 0.002 | 0.441 | Beta 2 adrenoreceptor antagonist | 0.152 0.004 DBMET01000 | ||
| 0.441 | 0.003 | 0.441 | Mucolytic | 0.234 0.008 DBMET01000 | ||
| 0.412 | 0.001 | 0.412 | Beta 2 adrenoreceptor agonist | 0.195 0.002 DBMET01000 | ||
| 0.444 | 0.039 | 0.625 | Antithrombotic | 0.625 0.014 DBMET01000 | DBMET01000 | |
| 0.422 | 0.02 | 0.422 | Vasodilator | 0.253 0.067 DBMET01000 | ||
| 0.406 | 0.022 | 0.406 | Calcium channel activator | 0.256 0.14 DBMET01000 | ||
| 0.4 | 0.022 | 0.4 | Psychostimulant | |||
| 0.365 | 0.002 | 0.365 | Adenylate cyclase stimulant | 0.339 0.002 DBMET01000 | ||
| 0.355 | 0.002 | 0.355 | Beta 1 adrenoreceptor antagonist | 0.137 0.005 DBMET01000 | ||
| 0.317 | 0.002 | 0.317 | Beta 3 adrenoreceptor agonist | 0.034 0.004 DBMET01000 | ||
| 0.309 | 0.003 | 0.309 | Beta 3 adrenoreceptor antagonist | 0.154 0.005 DBMET01000 | ||
| 0.318 | 0.019 | 0.318 | Peptidyltransferase inhibitor | 0.248 0.052 DBMET01000 | ||
| 0.381 | 0.085 | 0.381 | Histamine release inhibitor | 0.297 0.125 DBMET01000 | ||
| 0.306 | 0.01 | 0.306 | Nitric-oxide synthase stimulant | |||
| 0.294 | 0.017 | 0.294 | Insulin sensitizer | 0.206 0.068 DBMET01000 | ||
| 0.284 | 0.007 | 0.284 | Histidine decarboxylase inhibitor | |||
| 0.281 | 0.016 | 0.281 | Cholinergic antagonist | |||
| 0.276 | 0.016 | 0.276 | Acetylcholine antagonist | |||
| 0.302 | 0.052 | 0.302 | Hypoglycemic | |||
| 0.305 | 0.06 | 0.334 | Antioxidant | 0.334 0.051 DBMET01000 | DBMET01000 | |
| 0.245 | 0.005 | 0.245 | Phenylalanine 4-hydroxylase inhibitor | 0.101 0.025 DBMET01000 | ||
| 0.239 | 0.005 | 0.239 | Acetylcholine M3 receptor antagonist | |||
| 0.283 | 0.05 | 0.283 | DNA synthesis inhibitor | 0.181 0.152 DBMET01000 | ||
| 0.248 | 0.019 | 0.248 | Adenylate cyclase inhibitor | |||
| 0.25 | 0.023 | 0.25 | Alpha-N-acetylglucosaminidase inhibitor | |||
| 0.223 | 0.002 | 0.223 | Calcium-sensing receptor antagonist | 0.101 0.004 DBMET01000 | ||
| 0.236 | 0.017 | 0.236 | Acetylcholine muscarinic antagonist | |||
| 0.245 | 0.026 | 0.245 | Acetylcholine M1 receptor antagonist | |||
| 0.269 | 0.052 | 0.269 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.273 | 0.079 | 0.273 | 5 Hydroxytryptamine release stimulant | |||
| 0.256 | 0.066 | 0.256 | Free radical scavenger | 0.164 0.13 DBMET01000 | ||
| 0.282 | 0.096 | 0.282 | Sodium/bile acid cotransporter inhibitor | 0.226 0.155 DBMET01000 | ||
| 0.258 | 0.073 | 0.258 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.234 | 0.049 | 0.234 | Neurotrophic factor enhancer | |||
| 0.189 | 0.005 | 0.2 | Anabolic | 0.2 0.004 DBMET01000 | DBMET01000 | |
| 0.262 | 0.092 | 0.338 | Immunostimulant | 0.338 0.068 DBMET01000 | DBMET01000 | |
| 0.222 | 0.056 | 0.222 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.179 | 0.013 | 0.179 | Aminoacyl-tRNA synthetase inhibitor | 0.134 0.024 DBMET01000 | ||
| 0.19 | 0.036 | 0.19 | Monophenol monooxygenase inhibitor | |||
| 0.209 | 0.055 | 0.209 | Growth hormone agonist | |||
| 0.229 | 0.078 | 0.229 | Hypolipemic | |||
| 0.278 | 0.129 | 0.278 | Immunosuppressant | 0.205 0.192 DBMET01000 | ||
| 0.158 | 0.012 | 0.158 | Glutamate decarboxylase inhibitor | 0.082 0.043 DBMET01000 | ||
| 0.153 | 0.009 | 0.153 | Glutamate release inhibitor | |||
| 0.186 | 0.047 | 0.186 | Melanin inhibitor | |||
| 0.157 | 0.019 | 0.157 | Porphobilinogen synthase inhibitor | |||
| 0.196 | 0.06 | 0.196 | Peroxidase inhibitor | |||
| 0.156 | 0.023 | 0.156 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.169 | 0.055 | 0.169 | Amylase inhibitor | |||
| 0.257 | 0.145 | 0.257 | Calpain 2 inhibitor | |||
| 0.156 | 0.045 | 0.156 | Interleukin 4 antagonist | |||
| 0.195 | 0.087 | 0.195 | Interleukin antagonist | |||
| 0.139 | 0.033 | 0.139 | UDP-glucose 4-epimerase inhibitor | |||
| 0.179 | 0.077 | 0.179 | Nitric oxide antagonist | |||
| 0.134 | 0.032 | 0.134 | Sphingomyelinase inhibitor | |||
| 0.125 | 0.026 | 0.125 | Toll-Like receptor 3 antagonist | |||
| 0.296 | 0.198 | 0.296 | Caspase 9 stimulant | |||
| 0.119 | 0.026 | 0.119 | Ornithine decarboxylase inhibitor | |||
| 0.097 | 0.005 | 0.123 | Adenine nucleotide translocase inhibitor | 0.123 0.004 DBMET01000 | DBMET01000 | |
| 0.111 | 0.024 | 0.111 | Alpha adrenoreceptor agonist | |||
| 0.102 | 0.016 | 0.102 | Maillard reaction inhibitor | |||
| 0.145 | 0.062 | 0.145 | Pregnane X receptor agonist | 0.123 0.119 DBMET01000 | ||
| 0.183 | 0.103 | 0.397 | Angiogenesis stimulant | 0.397 0.022 DBMET01000 | DBMET01000 | |
| 0.136 | 0.059 | 0.136 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.088 | 0.014 | 0.088 | Gonadotropin-releasing hormone receptor agonist | 0.059 0.041 DBMET01000 | ||
| 0.131 | 0.058 | 0.131 | Proteasome inhibitor | |||
| 0.184 | 0.111 | 0.184 | Antiamyloidogenic | |||
| 0.092 | 0.021 | 0.092 | Carbonic anhydrase stimulant | |||
| 0.099 | 0.03 | 0.099 | Interferon agonist | 0.098 0.031 DBMET01000 | ||
| 0.14 | 0.072 | 0.14 | Ca2+-transporting ATPase inhibitor | |||
| 0.099 | 0.031 | 0.099 | Keratolytic | |||
| 0.077 | 0.012 | 0.095 | Alpha-mannosidase inhibitor | 0.095 0.007 DBMET01000 | DBMET01000 | |
| 0.093 | 0.034 | 0.093 | Phosphofructokinase-1 inhibitor | |||
| 0.096 | 0.037 | 0.096 | Somatostatin 1 agonist | |||
| 0.081 | 0.023 | 0.082 | Interferon inducer | 0.082 0.022 DBMET01000 | DBMET01000 | |
| 0.081 | 0.023 | 0.081 | Alpha 2 adrenoreceptor agonist | |||
| 0.136 | 0.08 | 0.259 | Cell wall synthesis inhibitor | 0.259 0.014 DBMET01000 | DBMET01000 | |
| 0.11 | 0.055 | 0.11 | Carbonic anhydrase XV inhibitor | |||
| 0.08 | 0.024 | 0.08 | Acetylcholine M5 receptor antagonist | |||
| 0.067 | 0.013 | 0.089 | Mannosidase inhibitor | 0.089 0.007 DBMET01000 | DBMET01000 | |
| 0.099 | 0.045 | 0.099 | NADH dehydrogenase inhibitor | |||
| 0.126 | 0.074 | 0.126 | Vanilloid 1 agonist | |||
| 0.156 | 0.108 | 0.156 | Anesthetic general | |||
| 0.057 | 0.011 | 0.057 | Diamine oxidase inhibitor | |||
| 0.212 | 0.166 | 0.212 | Ca(v)3.3 blocker | |||
| 0.094 | 0.048 | 0.094 | Interleukin 5 antagonist | |||
| 0.14 | 0.095 | 0.14 | CF transmembrane conductance regulator agonist | |||
| 0.051 | 0.006 | 0.051 | Sodium/glucose cotransporter 2 inhibitor | |||
| 0.21 | 0.167 | 0.21 | Apoptosis antagonist | |||
| 0.127 | 0.086 | 0.127 | Protein kinase stimulant | |||
| 0.113 | 0.072 | 0.134 | Cholesterol synthesis inhibitor | 0.134 0.054 DBMET01000 | DBMET01000 | |
| 0.088 | 0.049 | 0.088 | D-Ala-D-Ala ligase inhibitor | |||
| 0.094 | 0.055 | 0.249 | Triose-phosphate isomerase inhibitor | 0.249 0.007 DBMET01000 | DBMET01000 | |
| 0.126 | 0.087 | 0.126 | Lipid peroxidase inhibitor | |||
| 0.107 | 0.068 | 0.107 | Electron transport complex I inhibitor | |||
| 0.043 | 0.006 | 0.043 | Sodium/glucose cotransporter inhibitor | |||
| 0.052 | 0.015 | 0.052 | Nicotinic receptor beta4 subunit antagonist | |||
| 0.069 | 0.034 | 0.081 | Neuraminidase inhibitor | 0.081 0.024 DBMET01000 | DBMET01000 | |
| 0.085 | 0.051 | 0.085 | Estrogen-related receptor beta agonist | |||
| 0.045 | 0.011 | 0.046 | Ceramide glucosyltransferase inhibitor | 0.046 0.01 DBMET01000 | DBMET01000 | |
| 0.062 | 0.028 | 0.062 | Glucosylceramidase inhibitor | |||
| 0.052 | 0.019 | 0.057 | HIV-1 protease inhibitor | 0.057 0.014 DBMET01000 | DBMET01000 | |
| 0.053 | 0.022 | 0.053 | Cytokine production stimulant | |||
| 0.102 | 0.072 | 0.102 | DOPA decarboxylase inhibitor | |||
| 0.108 | 0.08 | 0.108 | Alkylator | |||
| 0.113 | 0.085 | 0.113 | Toll-Like receptor 2 antagonist | |||
| 0.067 | 0.039 | 0.096 | Neuraminidase (influenza) inhibitor | 0.096 0.018 DBMET01000 | DBMET01000 | |
| 0.124 | 0.096 | 0.124 | Farnesoid X receptor antagonist | |||
| 0.127 | 0.1 | 0.389 | Hemostatic | 0.389 0.008 DBMET01000 | DBMET01000 | |
| 0.033 | 0.009 | 0.044 | 1,3-Beta-glucan synthase inhibitor | 0.044 0.003 DBMET01000 | DBMET01000 | |
| 0.094 | 0.07 | 0.094 | Carbonic anhydrase III inhibitor | |||
| 0.063 | 0.04 | 0.063 | Purinergic P2X1 antagonist | |||
| 0.056 | 0.036 | 0.056 | Sphingosine 1-phosphate receptor 1 antagonist | |||
| 0.169 | 0.149 | 0.169 | Calpain inhibitor | |||
| 0.039 | 0.02 | 0.039 | Phosphoglycerate kinase inhibitor | 0.039 0.02 DBMET01000 | ||
| 0.083 | 0.064 | 0.083 | Transcription factor NF kappa B stimulant | |||
| 0.055 | 0.038 | 0.055 | Bombesin 3 receptor antagonist | |||
| 0.141 | 0.125 | 0.146 | Phospholipase C inhibitor | 0.146 0.114 DBMET01000 | DBMET01000 | |
| 0.05 | 0.034 | 0.05 | Potassium channel (Inward rectifier) blocker | |||
| 0.114 | 0.099 | 0.114 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.169 | 0.155 | 0.215 | RNA-directed DNA polymerase inhibitor | 0.215 0.08 DBMET01000 | DBMET01000 | |
| 0.071 | 0.059 | 0.083 | Na+ K+ transporting ATPase inhibitor | 0.083 0.048 DBMET01000 | DBMET01000 | |
| 0.088 | 0.075 | 0.088 | Creatine kinase inhibitor | |||
| 0.025 | 0.013 | 0.025 | Alpha 1a adrenoreceptor agonist | |||
| 0.141 | 0.13 | 0.141 | Succinate dehydrogenase inhibitor | |||
| 0.049 | 0.038 | 0.049 | Factor III inhibitor | |||
| 0.067 | 0.057 | 0.168 | Cathepsin G inhibitor | 0.168 0.019 DBMET01000 | DBMET01000 | |
| 0.092 | 0.082 | 0.092 | Adenylate kinase inhibitor | |||
| 0.06 | 0.051 | 0.06 | Leukotriene antagonist | |||
| 0.048 | 0.04 | 0.048 | Alpha 1b adrenoreceptor agonist | |||
| 0.102 | 0.095 | 0.102 | Nav1.3 sodium channel blocker | |||
| 0.072 | 0.065 | 0.072 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.093 | 0.087 | 0.142 | Nav1.4 sodium channel blocker | 0.142 0.037 DBMET01000 | DBMET01000 | |
| 0.088 | 0.084 | 0.088 | Mediator release inhibitor | |||
| 0.068 | 0.064 | 0.068 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.103 | 0.099 | 0.103 | Cyclooxygenase 3 inhibitor | |||
| 0.028 | 0.025 | 0.028 | Prostaglandin D2 agonist | |||
| 0.016 | 0.014 | 0.016 | Ileal bile acid transport inhibitor | |||
| 0.019 | 0.019 | 0.026 | Follicle-stimulating hormone agonist | 0.026 0.012 DBMET01000 | DBMET01000 | |
| 0.13 | 0.134 | 0.169 | Hepatoprotectant | 0.169 0.09 DBMET01000 | DBMET01000 | |
| 0.159 | 0.172 | 0.188 | Superoxide dismutase inhibitor | 0.188 0.132 DBMET01000 | DBMET01000 | |
| 0.04 | 0.058 | 0.111 | Factor IXa inhibitor | 0.111 0.008 DBMET01000 | DBMET01000 | |
| 0.2 | 0.229 | 0.319 | Antibacterial | 0.319 0.121 DBMET01000 | DBMET01000 | |
| 0.049 | 0.087 | 0.133 | Carbonic anhydrase XIII inhibitor | 0.133 0.025 DBMET01000 | DBMET01000 | |
| 0.043 | 0.088 | 0.063 | Sphingosine kinase inhibitor | 0.063 0.034 DBMET01000 | DBMET01000 | |
| 0.036 | 0.084 | 0.188 | Selectin antagonist | 0.188 0.013 DBMET01000 | DBMET01000 | |
| 0.018 | 0.08 | 0.079 | Estrogen agonist | 0.079 0.023 DBMET01000 | DBMET01000 | |
| 0.055 | 0.121 | 0.101 | Aminopeptidase B inhibitor | 0.101 0.064 DBMET01000 | DBMET01000 | |
| 0.046 | 0.145 | 0.081 | Glycine receptor antagonist | 0.081 0.056 DBMET01000 | DBMET01000 | |
| 0.052 | 0.163 | 0.118 | Gastric antisecretory | 0.118 0.045 DBMET01000 | DBMET01000 | |
| 0.03 | 0.143 | 0.087 | HIV-1 integrase (3'-Processing) inhibitor | 0.087 0.031 DBMET01000 | DBMET01000 | |
| 0.025 | 0.148 | 0.101 | Carbonic anhydrase V inhibitor | 0.101 0.027 DBMET01000 | DBMET01000 | |
| 0.026 | 0.169 | 0.066 | Carbonic anhydrase VA inhibitor | 0.066 0.051 DBMET01000 | DBMET01000 | |
| 0.02 | 0.164 | 0.086 | HIV-1 integrase (Strand Transfer) inhibitor | 0.086 0.028 DBMET01000 | DBMET01000 | |
| 0.035 | 0.187 | 0.107 | CDC25A inhibitor | 0.107 0.024 DBMET01000 | DBMET01000 | |
| 0.063 | 0.22 | 0.097 | Acetylcholine release stimulant | 0.097 0.094 DBMET01000 | DBMET01000 | |
| 0.079 | 0.24 | 0.233 | Dual specificity phosphatase inhibitor | 0.233 0.042 DBMET01000 | DBMET01000 | |
| 0.077 | 0.251 | 0.303 | Platelet adhesion inhibitor | 0.303 0.033 DBMET01000 | DBMET01000 | |
| 0.062 | 0.262 | 0.315 | Diuretic | 0.315 0.02 DBMET01000 | DBMET01000 | |
| 0.005 | 0.208 | 0.282 | Cholecystokinin A antagonist | 0.282 0.004 DBMET01000 | DBMET01000 | |
| 0.052 | 0.257 | 0.192 | Protein-tyrosine phosphatase inhibitor | 0.192 0.05 DBMET01000 | DBMET01000 | |
| 0.004 | 0.218 | 0.21 | Cholecystokinin B antagonist | 0.21 0.004 DBMET01000 | DBMET01000 | |
| 0.018 | 0.243 | 0.192 | NMDA 2B receptor antagonist | 0.192 0.006 DBMET01000 | DBMET01000 | |
| 0.011 | 0.237 | 0.041 | Leukocyte elastase inhibitor | 0.041 0.032 DBMET01000 | DBMET01000 | |
| 0.005 | 0.239 | 0.234 | Cholecystokinin antagonist | 0.234 0.004 DBMET01000 | DBMET01000 | |
| 0.004 | 0.242 | 0.038 | Estrone sulfatase inhibitor | 0.038 0.009 DBMET01000 | DBMET01000 | |
| 0.014 | 0.253 | 0.028 | Toll-Like receptor 4 agonist | 0.028 0.014 DBMET01000 | DBMET01000 | |
| 0.014 | 0.27 | 0.567 | Cholecystokinin B agonist | 0.567 0.002 DBMET01000 | DBMET01000 | |
| 0.04 | 0.358 | 0.202 | Dual specificity phosphatase 3 inhibitor | 0.202 0.06 DBMET01000 | DBMET01000 | |
| 0.006 | 0.408 | 0.037 | NMDA 2D receptor antagonist | 0.037 0.011 DBMET01000 | DBMET01000 | |
| 0.009 | 0.486 | 0.052 | Elastase inhibitor | 0.052 0.039 DBMET01000 | DBMET01000 | |
| 0.015 | 0.595 | 0.317 | Anticoagulant | 0.317 0.026 DBMET01000 | DBMET01000 | |
| 0.003 | 0.706 | 0.367 | Cholecystokinin agonist | 0.367 0.002 DBMET01000 | DBMET01000 | |
| 0.003 | 0.749 | 0.272 | Cholecystokinin A agonist | 0.272 0.002 DBMET01000 | DBMET01000 | |
| 0.007 | 0.887 | 0.121 | Multidrug resistance-associated protein 1 inhibitor | 0.121 0.048 DBMET01000 | DBMET01000 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |